Free Trial
NYSE:USPH

U.S. Physical Therapy (USPH) Stock Price, News & Analysis

$98.32
+1.32 (+1.36%)
(As of 07/26/2024 ET)
Today's Range
$97.46
$98.66
50-Day Range
$90.75
$106.60
52-Week Range
$78.08
$122.20
Volume
117,026 shs
Average Volume
106,206 shs
Market Capitalization
$1.48 billion
P/E Ratio
79.93
Dividend Yield
1.79%
Price Target
$119.50

U.S. Physical Therapy MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
21.5% Upside
$119.50 Price Target
Short Interest
Healthy
3.53% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.59mentions of U.S. Physical Therapy in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.11 M Sold Last Quarter
Proj. Earnings Growth
9.51%
From $2.84 to $3.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.58 out of 5 stars

Medical Sector

503rd out of 936 stocks

Health Services Industry

4th out of 11 stocks

USPH stock logo

About U.S. Physical Therapy Stock (NYSE:USPH)

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

USPH Stock Price History

USPH Stock News Headlines

Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.
Q1 2024 US Physical Therapy Inc Earnings Call
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Ex-Dividend for 6/14 Dividend
5/22/2024
Dividend Payable
6/14/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
Health Care Facilities
CUSIP
90337L10
Employees
6,720
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$119.50
High Stock Price Target
$122.00
Low Stock Price Target
$117.00
Potential Upside/Downside
+21.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$28.24 million
Pretax Margin
8.13%

Debt

Sales & Book Value

Annual Sales
$604.80 million
Cash Flow
$4.76 per share
Book Value
$31.85 per share

Miscellaneous

Free Float
14,812,000
Market Cap
$1.48 billion
Optionable
Optionable
Beta
1.38
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives


USPH Stock Analysis - Frequently Asked Questions

How have USPH shares performed this year?

U.S. Physical Therapy's stock was trading at $93.14 at the start of the year. Since then, USPH stock has increased by 5.6% and is now trading at $98.32.
View the best growth stocks for 2024 here
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Tuesday, May, 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.07. U.S. Physical Therapy's revenue was up 4.8% compared to the same quarter last year.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are U.S. Physical Therapy's major shareholders?

Top institutional shareholders of U.S. Physical Therapy include Boston Trust Walden Corp (3.62%), Bank of New York Mellon Corp (1.04%), Chatham Capital Group Inc. (0.13%) and Raymond James & Associates (0.12%). Insiders that own company stock include Christopher J Reading, Carey P Hendrickson, Eric Joseph Williams, Kathleen A Gilmartin, Richard Binstein, Glenn Mcdowell, Mark J Brookner, Harry S Chapman, Clayton Trier, Graham D Reeve, Edward L Kuntz and Anne Motsenbocker.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM) and Illumina (ILMN).

This page (NYSE:USPH) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners